Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SOX9 ELISA Kit (AC3291)
Cat.#: ASET-1880
Specifications
Description Human SOX9 ELISA Kit allows for the in vitro quantitative determination of human SOX9 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2078 Rat CDNF ELISA Kit (AC3489) Quantitative inquiry ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-1854 Human FGF1 ELISA Kit (AC3265) Quantitative inquiry ASET-1387 Human beta 1 Adrenergic Receptor ELISA Kit (AC2798) Quantitative inquiry ASET-1876 Human TNF Receptor II ELISA Kit (AC3287) Quantitative inquiry ASET-2526 Human Estrogen Receptor alpha ELISA Kit (AC3937) Quantitative inquiry ASET-1774 Bovine Ghrelin ELISA Kit (AC3185) Quantitative inquiry ASET-2238 Mouse Rilpl2 ELISA Kit (AC3649) Quantitative inquiry ASET-1687 Mouse Neogenin ELISA Kit (AC3098) Quantitative inquiry ASET-1878 Human NMDAR2B ELISA Kit (AC3289) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket